[go: up one dir, main page]

PL2123656T3 - Sposób wytwarzania chlorowodorku prasugrelu o wysokiej czystości - Google Patents

Sposób wytwarzania chlorowodorku prasugrelu o wysokiej czystości

Info

Publication number
PL2123656T3
PL2123656T3 PL08712139T PL08712139T PL2123656T3 PL 2123656 T3 PL2123656 T3 PL 2123656T3 PL 08712139 T PL08712139 T PL 08712139T PL 08712139 T PL08712139 T PL 08712139T PL 2123656 T3 PL2123656 T3 PL 2123656T3
Authority
PL
Poland
Prior art keywords
production
high purity
prasugrel hydrochloride
prasugrel
hydrochloride
Prior art date
Application number
PL08712139T
Other languages
English (en)
Inventor
Hiroyuki Miyata
Yukinori Wada
Naoyuki Yokota
Original Assignee
Daiichi Sankyo Co Ltd
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39738173&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2123656(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Sankyo Co Ltd, Ube Industries filed Critical Daiichi Sankyo Co Ltd
Publication of PL2123656T3 publication Critical patent/PL2123656T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL08712139T 2007-03-02 2008-02-29 Sposób wytwarzania chlorowodorku prasugrelu o wysokiej czystości PL2123656T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007053093 2007-03-02
EP08712139.8A EP2123656B1 (en) 2007-03-02 2008-02-29 Process for production of prasugrel hydrochloride having high purity
PCT/JP2008/053617 WO2008108291A1 (ja) 2007-03-02 2008-02-29 高純度のプラスグレル塩酸塩の製造方法

Publications (1)

Publication Number Publication Date
PL2123656T3 true PL2123656T3 (pl) 2014-11-28

Family

ID=39738173

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08712139T PL2123656T3 (pl) 2007-03-02 2008-02-29 Sposób wytwarzania chlorowodorku prasugrelu o wysokiej czystości

Country Status (23)

Country Link
US (2) US20100094013A1 (pl)
EP (1) EP2123656B1 (pl)
JP (1) JP5363307B2 (pl)
KR (1) KR101505212B1 (pl)
CN (2) CN101675058A (pl)
AU (1) AU2008222000B2 (pl)
CA (1) CA2679925C (pl)
CO (1) CO6210821A2 (pl)
CY (1) CY1115518T1 (pl)
DK (1) DK2123656T3 (pl)
ES (1) ES2487190T3 (pl)
HR (1) HRP20140668T1 (pl)
IL (1) IL200647A (pl)
MX (1) MX2009009413A (pl)
MY (1) MY151726A (pl)
NZ (1) NZ579993A (pl)
PL (1) PL2123656T3 (pl)
PT (1) PT2123656E (pl)
RU (1) RU2435776C2 (pl)
SI (1) SI2123656T1 (pl)
TW (1) TWI417295B (pl)
WO (1) WO2008108291A1 (pl)
ZA (1) ZA200906850B (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2152078B8 (en) 2007-04-27 2021-03-17 CyDex Pharmaceuticals, Inc. Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
US20100261908A1 (en) * 2007-11-09 2010-10-14 Dr. Reddy's Laboratories Ltd. Processes for the preparation of prasugrel , and its salts and polymorphs
CN101684124B (zh) * 2008-09-22 2013-11-13 广州赫尔氏药物开发有限公司 新的具有抗凝血作用的化合物
CN103936756B (zh) * 2008-09-22 2017-09-19 广州赫尔氏药物开发有限公司 具有抗凝血作用的化合物
CN101486635B (zh) * 2009-02-27 2012-10-10 上海医药工业研究院 α-环丙基羰基-2-氟苄基卤素的制备方法
WO2010132711A1 (en) 2009-05-13 2010-11-18 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
CN101993447A (zh) * 2009-08-26 2011-03-30 浙江华海药业股份有限公司 一种人工合成普拉格雷的方法
HU229031B1 (en) 2009-12-21 2013-07-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing prasurgel and its intermediate
HU229035B1 (en) 2009-12-21 2013-07-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing prasurgel
CN101735241A (zh) * 2009-12-24 2010-06-16 浙江普洛家园药业有限公司 普拉格雷中间体及其制备方法
WO2011110219A1 (en) 2010-03-09 2011-09-15 Synthon Bv A process for making prasugrel
WO2011117782A1 (en) * 2010-03-23 2011-09-29 Alembic Pharmaceuticals Limited A process for the preparation of prasugrel hcl salt
WO2012001486A1 (en) * 2010-06-28 2012-01-05 Mayuka Labs Pvt. Ltd. An improved process for the preparation of prasugrel hydrochloride and its intermediates
US20130274284A1 (en) * 2010-08-06 2013-10-17 Dr. Reddy's Laboratories, Inc. Preparation of prasugrel hydrochloride
CN101948479B (zh) * 2010-09-29 2013-01-30 横店集团家园化工有限公司 普拉格雷中间体及其制备方法
HUP1000565A2 (en) 2010-10-22 2012-05-02 Egis Gyogyszergyar Nyrt Process for the preparation of pharmaceutically active compound and intermediers
CN102101827B (zh) * 2010-11-15 2013-07-03 山东新华制药股份有限公司 一种普拉格雷中间体α-环丙羰基-2-氟苄基卤的制备方法
KR101552691B1 (ko) * 2011-04-14 2015-09-11 광저우 히어쉬 파머 디벨롭먼트 컴퍼니 리미티드 신규한 항-혈소판 화합물의 부가염
CN102746318A (zh) * 2011-04-20 2012-10-24 上海信谊药厂有限公司 用于制备普拉格雷盐酸盐的方法
CN102276623A (zh) * 2011-06-13 2011-12-14 安徽省虹升生物科技有限公司 一种利用有机硅保护剂进行制备普拉格雷的新方法
CN102838618A (zh) 2011-06-22 2012-12-26 广东东阳光药业有限公司 一种制备普拉格雷的方法及普拉格雷盐酸盐新晶型
WO2013024399A1 (en) * 2011-08-12 2013-02-21 Alembic Pharmaceuticals Limited Improved method for quantitative determination of prasugrel hydrochloride
CN102977115B (zh) * 2012-11-16 2015-01-21 江苏先声药业有限公司 普拉格雷游离碱的合成新方法
CN105085541A (zh) * 2014-05-07 2015-11-25 江苏先声药业有限公司 一种普拉格雷类似物的制备方法
HU231079B1 (hu) 2016-06-23 2020-06-29 Richter Gedeon Nyrt. Eljárás nagytisztaságú Prasugrel előállítására bromopentil szennyezés eltávolításával
CN112047959A (zh) * 2020-10-21 2020-12-08 深圳市祥根生物科技有限公司 一种普拉格雷开环氯代杂质的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3736664A1 (de) * 1987-10-29 1989-05-11 Boehringer Ingelheim Kg Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
JP3840662B2 (ja) * 1994-10-07 2006-11-01 宇部興産株式会社 ２−シリルオキシ−テトラヒドロチエノピリジン類、その塩およびその製造方法
JP4001199B2 (ja) * 2000-07-06 2007-10-31 第一三共株式会社 ヒドロピリジン誘導体酸付加塩
HU227746B1 (en) * 2000-07-06 2012-02-28 Ube Industries Hydropyridine derivative acid addition salts, process for their preparation, pharmaceutical compositions containing them and their use
EP1350511B1 (en) * 2000-12-25 2008-09-10 Daiichi Sankyo Company, Limited Medicinal compositions containing aspirin
JP4029974B2 (ja) * 2001-12-21 2008-01-09 第一三共株式会社 ヒドロピリジン誘導体酸付加塩を含有する医薬
EP1660183A2 (en) * 2003-05-05 2006-05-31 Eli Lilly and Company Treating cardiovascular diseases with a compound of formula 1 (cs 747 - prasugrel; rn 150322-43-4)
TWI318571B (en) * 2005-06-10 2009-12-21 Lilly Co Eli Formulation of a thienopyridine platelet aggregation inhibitor
TWI392681B (zh) * 2006-04-06 2013-04-11 Daiichi Sankyo Co Ltd 高純度普拉格雷及其酸加成鹽之製法

Also Published As

Publication number Publication date
IL200647A0 (en) 2010-05-17
MY151726A (en) 2014-06-30
ES2487190T3 (es) 2014-08-20
MX2009009413A (es) 2009-09-11
TWI417295B (zh) 2013-12-01
HRP20140668T1 (hr) 2014-10-10
CN101675058A (zh) 2010-03-17
US20130345428A1 (en) 2013-12-26
HK1136278A1 (en) 2010-06-25
AU2008222000B2 (en) 2012-06-14
EP2123656A1 (en) 2009-11-25
SI2123656T1 (sl) 2014-09-30
JPWO2008108291A1 (ja) 2010-06-17
PT2123656E (pt) 2014-09-08
DK2123656T3 (da) 2014-09-08
EP2123656A4 (en) 2011-05-04
NZ579993A (en) 2012-06-29
US20100094013A1 (en) 2010-04-15
CO6210821A2 (es) 2010-10-20
CY1115518T1 (el) 2017-01-04
CA2679925C (en) 2012-10-02
JP5363307B2 (ja) 2013-12-11
KR20090127267A (ko) 2009-12-10
RU2009136445A (ru) 2011-04-10
BRPI0808034A2 (pt) 2014-06-17
TW200844104A (en) 2008-11-16
CN102424686A (zh) 2012-04-25
CA2679925A1 (en) 2008-09-12
WO2008108291A1 (ja) 2008-09-12
EP2123656B1 (en) 2014-06-11
IL200647A (en) 2015-02-26
RU2435776C2 (ru) 2011-12-10
ZA200906850B (en) 2010-06-30
KR101505212B1 (ko) 2015-03-23
AU2008222000A1 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
ZA200906850B (en) Process for production of prasugrel hydrochloride having high purity
LT2003136T (lt) Labai gryno prasugrelio hidrochlorido gavimo būdas
IL191125A0 (en) Process for production of cinnamide derivative
PT2144851T (pt) Processo para produção de pcc
IL199295A (en) Process for the production of an anthranilamide compound
IL220430A0 (en) Process for the production of benzopyran-2-ol derivatives
EP2241630A4 (en) PROCESS FOR PRODUCING ORGANIC ACID
IL206332A0 (en) Process for production of radioactive-fluorine-labeled organic compound
EP2088136A4 (en) PROCESS FOR PRODUCING HYDROXYADAMANTANE-AMINE
PL1990336T3 (pl) Sposób wytwarzania związku 5-alkoksy-4-hydroksymetylopirazolowego
IL187155A0 (en) Process for production of 4-biphenylazetidin-2-ones
EP2028181A4 (en) PROCESS FOR PRODUCING GLYCIDOL
IL200281A0 (en) Process for production of tablet
ZA201005788B (en) Process for production of thiophene compound and intermediate thereof
ZA200710066B (en) Process for production of 4-biphenylylazetidin-2-ones
EP2221294A4 (en) PROCESS FOR PREPARING N-CARBAMOYL-TERT.-LEUCIN
EP2423187A4 (en) PROCESS FOR PRODUCING N-ALCOXYCARBONYL-tert-LEUCINS
EP1947083A4 (en) PROCESS FOR THE PREPARATION OF ARALKYLOXYPYRROLIDINE DERIVATIVES
EP1988073A4 (en) PROCESS FOR PRODUCING AN AMIDE-TYPE BETA-AMINO-ALPHA-HYDROXYACID DERIVATIVE
EP2251329A4 (en) PROCESS FOR THE PRODUCTION OF 3-AMINO-2-CHLORO-6-TRIFLUOROMETHYLPYRIDINE
EP2181125A4 (en) PROCESS FOR PRODUCING HIGH-PURITY EXO-ALKENYLNORBORNENES
EP2221290A4 (en) PROCESS FOR THE PREPARATION OF ALKOXYINDANONE DERIVATIVES
EP1864993A4 (en) METHOD FOR PRODUCING A GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE
HU0800226D0 (en) Process for producing high purity compounds comprising n-atom
EP2098518A4 (en) PROCESS FOR THE PRODUCTION OF EXTREMELY PURE QUATERNARY AMMONIUM SALT